Laura A Johnson

Laura A Johnson

GlaxoSmithKline - Needham / United Kingdom
Others
AD Scientific Index ID: 4370859
-
person_outline Laura A Johnson's MOST POPULAR ARTICLES
1-) Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impairedM Ahmadzadeh, LA Johnson, B Heemskerk, JR Wunderlich, ME Dudley, ...Blood 114 (8), 1537-1544, 200917282009
2-) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenLA Johnson, RA Morgan, ME Dudley, L Cassard, JC Yang, MS Hughes, ...Blood 114 (3), 535-546, 200915442009
3-) Engineered CAR T cells targeting the cancer-associated Tn-glycoform of the membrane mucin MUC1 control adenocarcinomaAD Posey Jr, RD Schwab, AC Boesteanu, C Steentoft, U Mandel, ...Immunity 44 (6), 1444-1454, 20164492016
4-) Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicityLCS Wang, A Lo, J Scholler, J Sun, RS Majumdar, V Kapoor, M Antzis, ...Cancer immunology research 2 (2), 154-166, 20146002014
5-) Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastomaLA Johnson, J Scholler, T Ohkuri, A Kosaka, PR Patel, SE McGettigan, ...Science translational medicine 7 (275), 275ra22-275ra22, 20155272015